Ardelyx Inc., of Fremont, Calif., appointed Jeremy S. Caldwell executive vice president and chief scientific officer.
Idera Pharmaceuticals Inc., of Cambridge, Mass., appointed Vincent J. Milano CEO, and Robert A. Doody Jr. vice president, investor relations and corporate communications.
Juno Therapeutics Inc., of Seattle, appointed Jeffrey Bluestone scientific advisor.
Kalobios Pharmaceuticals Inc., of South San Francisco, added Robert A. Baffi to its board.
Nucana Biomed Ltd., of Edinburgh, Scotland, added Paolo Paoletti to its board.
Rana Therapeutics Inc., of Cambridge, Mass., named Ronald C. Renaud CEO.
Vyome BioSciences, of New Delhi, India, named Richard Buchta senior vice-president of research and development, and added Ranjan Pai to its board.
Ziarco Group Ltd., of Canterbury, UK, added Mike Grey to its board.